tailieunhanh - Generation and characterization of MEK and ERK inhibitors- resistant non-smallcells-lung-cancer (NSCLC) cells

The RAS/RAF/MEK/ERK pathway is one of the most downregulated pathway in cancer. Inhibitors of RAF and MEK have established clinical use while ERK inhibitors recently faced the clinic. We aimed to generate resistant cell lines which could be helpful for defining new combinations able to overcome resistance. | Generation and characterization of MEK and ERK inhibitors- resistant non-smallcells-lung-cancer NSCLC cells

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN